We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$156B
AUM Growth
+$3.84B
Cap. Flow
-$1.51B
Cap. Flow %
-0.97%
Top 10 Hldgs %
22.2%
Holding
5,888
New
274
Increased
2,819
Reduced
1,798
Closed
330

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$436M
2
UTHR icon
United Therapeutics
UTHR
+$393M
3
AMZN icon
Amazon
AMZN
+$376M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$372M
5
V icon
Visa
V
+$364M

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Consumer Discretionary 6.77%
3 Healthcare 6.2%
4 Financials 5.48%
5 Communication Services 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
4926
DELISTED
Centessa Pharmaceuticals
CNTA
$11.1K ﹤0.01%
1,228
+1,024
+502% +$9.71K
OVID icon
4927
Ovid Therapeutics
OVID
$424M
$11K ﹤0.01%
14,316
+2,864
+25% +$7.97K
EWUS icon
4928
iShares MSCI United Kingdom Small-Cap ETF
EWUS
$41.5M
$11K ﹤0.01%
310
PVLA
4929
Palvella Therapeutics
PVLA
$1.99B
$10.9K ﹤0.01%
1,108
+1
+0.1% +$11
BYFC icon
4930
Broadway Financial
BYFC
$93.7M
$10.9K ﹤0.01%
2,122
-2,444
-54% -$12.3K
TTT icon
4931
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.3M
$10.8K ﹤0.01%
145
SPMB icon
4932
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7B
$10.8K ﹤0.01%
500
MRDN
4933
Meridian Holdings Inc
MRDN
$173M
$10.7K ﹤0.01%
+361
New +$16.6K
SCHM icon
4934
Schwab US Mid-Cap ETF
SCHM
$14.5B
$10.7K ﹤0.01%
411
+120
+41% +$3.14K
FAB icon
4935
First Trust Multi Cap Value AlphaDEX Fund
FAB
$166M
$10.6K ﹤0.01%
+135
New +$10.8K
SGU icon
4936
Star Group
SGU
$420M
$10.6K ﹤0.01%
999
+219
+28% +$2.36K
WEAT icon
4937
Teucrium Wheat Fund
WEAT
$294M
$10.6K ﹤0.01%
400
SMWB icon
4938
Similarweb
SMWB
$625M
$10.6K ﹤0.01%
1,365
+94
+7% +$732
CQP icon
4939
Cheniere Energy
CQP
$30.9B
$10.5K ﹤0.01%
214
+5
+2% +$243
CTXR icon
4940
Citius Pharmaceuticals
CTXR
$13.7M
$10.5K ﹤0.01%
720
-276
-28% -$4.95K
RMBI icon
4941
Richmond Mutual Bancorp
RMBI
$249M
$10.5K ﹤0.01%
892
-1,533
-63% -$17.6K
SLND icon
4942
Southland Holdings
SLND
$32.8M
$10.4K ﹤0.01%
2,263
+1,505
+199% +$7.42K
DIV icon
4943
Global X SuperDividend US ETF
DIV
$799M
$10.3K ﹤0.01%
+600
New +$10.3K
OPAD icon
4944
Offerpad Solutions
OPAD
$19.7M
$10.3K ﹤0.01%
233
-3,283
-93% -$204K
TELA icon
4945
TELA Bio
TELA
$31.3M
$10.3K ﹤0.01%
2,186
-483
-18% -$2.55K
VCSA
4946
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$10.3K ﹤0.01%
2,105
-54,512
-96% -$300K
VHI icon
4947
Valhi
VHI
$395M
$10.2K ﹤0.01%
571
+89
+18% +$1.52K
PSK icon
4948
State Street SPDR ICE Preferred Securities ETF
PSK
$691M
$10.2K ﹤0.01%
300
-193
-39% -$6.52K
GALT icon
4949
Galectin Therapeutics
GALT
$215M
$10.1K ﹤0.01%
+4,485
New +$13.6K
HIBL icon
4950
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$71.2M
$10K ﹤0.01%
240

Similar funds

Citigroup's Q2 2024 Portfolio in Review

As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
  • Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
  • Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
  • Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
  • Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
  • Citigroup opened 274 new positions and closed 330 in Q2 2024.
  • Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.

Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.